Centric Health Corp. (TSE:CRX – Free Report) – Equities researchers at Desjardins decreased their FY2024 EPS estimates for shares of Centric Health in a research report issued to clients and investors on Sunday, November 10th. Desjardins analyst G. Ho now anticipates that the company will earn ($0.03) per share for the year, down from their prior estimate of ($0.02).
Other equities research analysts also recently issued research reports about the stock. Ventum Cap Mkts upgraded shares of Centric Health to a “strong-buy” rating in a research report on Thursday, August 8th. Stifel Canada downgraded Centric Health from a “strong-buy” rating to a “hold” rating in a research note on Monday, August 12th.
Centric Health Stock Performance
Further Reading
- Five stocks we like better than Centric Health
- 3 Warren Buffett Stocks to Buy Now
- 3 GARP Stocks Offering Strong Growth: Aptiv, Allstate, Barrick
- The 3 Best Blue-Chip Stocks to Buy Now
- Mouse Rising: The Iger Investment Pays Off for Disney Investors
- How to Calculate Options Profits
- Can CAVA Stock Be the Next Chipotle? Earnings Can Help
Receive News & Ratings for Centric Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Centric Health and related companies with MarketBeat.com's FREE daily email newsletter.
